WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 9'1901 Infant (under 12 months) mortality rate: 82
GDP / capita (US$): 14'6101 Child (under 5 years) mortality rate: 92

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 4'647  4'478  4'341  4'247  4'186  3'235  2'703  2'605 
Births 62  60  57  56  54  62  68  78 
Surviving infants 61  59  57  55  54  61  66  75 
Pop. less than 5 years 281  269  273  276  289  305  311  366 
Pop. less than 15 years 1'003  1'009  1'029  1'041  1'064  927  923  1'017 
Female 15-49 years 1'303  1'232  1'168  1'132  1'105  885  688  626 

Number of reported case

(Click for retrospective incidence data for Lebanon)
Diphtheria
Japanese encephalitis
Measles 12  22  24 
Mumps 12  12  28  135  229  23 
Pertussis 53  19  65  50 
Polio*
Rubella 21  18 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Lebanon)
Vaccine year result method % card seen                                                
BCG         
DTP1 2008  84  MICS   54.6  99  98  98  96  99  93 
DTP3 2008  72  MICS   54.6  95  95  94  93  93  90  82 
HepB_BD          94  99  98  96  93  90 
HepB3 2008  72  MICS   54.6  95  95  94  93  93  70 
Hib3 2008  72  MICS   54.6  95  95  94  93  93 
JapEnc         
MCV 2008  79  MICS   54.6  98  98  95  93  89  90  39 
MCV2          88  86  89  88  71  87 
PCV1         
PCV3         
Pol3 2008  74  MICS   54.6  96  96  94  93  94  90  82 
Rota1         
Rota_last         
Rubella1          98  98  95  93  89 
TT2plus         
PAB         
VAD1         
YFV 2003  50  PAPFAM   62.0 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Lebanon)
DTP1 84  84  84  84  84  90  94  17 
DTP3 82  82  81  81  81  83  82 
HepB3 84  83  82  82  81  83 
Hib3 82  82  81  81  81 
MCV 80  80  80  79  79  71  61 
PCV3
Pol3 77  77  76  76  75  83  82 
Rota_last

Number of districts in the country 26  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DT Yes drop outs and children having problems with pertussis
DTwP 4-5 years; Yes
DTwPHib 18 months; Yes
DTwPHibHepB 2, 4, 6 months;
HepB birth; Yes and HCW
IPV 2 months;
MMR 12 months; 4-5 years; Yes
Measles 9 months; Yes
OPV 4, 6 months; Yes
Pneumo_conj Yes From January 2014
Td 10-12, 16-18 years; Yes
YF Pilgrims

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2014  2010-2014  2010-2014  2010- 2014  2009-2013  2007-2009  2007-2009 
Nº of districts with microplans that include activities to raise immunization coverage number 20  18  17  15  25 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 26  26  26  26  26  25  25 
Nº districts with DTP3 coverage >=80% number 26  26  25  26   
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  96  100   
Nº districts with measles (MCV1) coverage >=95% number 18  11  12     
% of districts with MCV1 coverage >=95% From 0 to 100% 69  23  35  42  46     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100    100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.